Abstract: The present disclosure is directed to methods of modulating pericytes in subjects in need thereof.

Abstract: The present disclosure is directed to methods of increasing remyelination in subjects in need thereof.

Abstract: The present disclosure is directed to methods of modulating corticosteroid responses in subjects in need thereof.

Abstract: A polyethylene composition comprising a granular polyethylene resin characterized by a resin solid density of from 0.91 to 0.97 g/cm3, a ratio of intraparticle void volume to interparticle void volume of from 0.33 to 0.67, and a total resin porosity, ?total, of equal to or greater than 0.45 is provided. Further provided are articles made from the polyethylene composition.

Abstract: A method for the delivery of a catalyst to a polymerization reactor is disclosed, comprising: contacting a catalyst with a carrier fluid comprising an inert hydrocarbon in gaseous form, the inert hydrocarbon having a normal boiling point of about ?1° C. to about 81° C.; and flowing the carrier fluid to the polymerization reactor such that the carrier fluid transports the catalyst to the polymerization reactor. A catalyst delivery system is disclosed, comprising: a catalyst vessel for containing a catalyst; a catalyst injection line for delivering the catalyst to a polymerization reactor, the catalyst injection line being in fluid communication with the catalyst vessel and the polymerization reactor; and a carrier fluid line in fluid communication with the catalyst injection line for delivering a carrier fluid comprising an inert hydrocarbon to the catalyst injection line, the inert hydrocarbon having a normal boiling point of about ?1° C. to about 81° C.

Abstract: A polyethylene composition comprising a granular polyethylene resin characterized by a resin solid density of from 0.91 to 0.97 g/cm3, a ratio of intraparticle void volume to interparticle void volume of from 0.33 to 0.67, and a total resin porosity, ?total, of equal to or greater than 0.45 is provided.

Abstract: Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I: in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification.

Abstract: A method for the delivery of a catalyst to a polymerization reactor is disclosed, comprising: contacting a catalyst with a carrier fluid comprising an inert hydrocarbon in gaseous form, the inert hydrocarbon having a normal boiling point of about ?1° C. to about 81° C.; and flowing the carrier fluid to the polymerization reactor such that the carrier fluid transports the catalyst to the polymerization reactor. A catalyst delivery system is disclosed, comprising: a catalyst vessel for containing a catalyst; a catalyst injection line for delivering the catalyst to a polymerization reactor, the catalyst injection line being in fluid communication with the catalyst vessel and the polymerization reactor; and a carrier fluid line in fluid communication with the catalyst injection line for delivering a carrier fluid comprising an inert hydrocarbon to the catalyst injection line, the inert hydrocarbon having a normal boiling point of about ?1° C. to about 81° C.

Abstract: The invention provides an ethylene-based interpolymer comprising the following features: a) density from 0.910 to 0.930 g/cc; b) melt index (I2) from 0.1 to 0.5 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.928 g/cc; b) a melt index (I2) from 0.1 to 0.8 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a hollow tube comprising at least one component formed from a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.

Abstract: Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I: in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification.

Abstract: Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Abstract: The invention provides an ethylene-based interpolymer comprising the following features: a) density from 0.910 to 0.930 g/cc; b) melt index (I2) from 0.1 to 0.5 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.928 g/cc; b) a melt index (I2) from 0.1 to 0.8 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a hollow tube comprising at least one component formed from a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.

Abstract: Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Abstract: The invention provides an ethylene-based interpolymer comprising the following features: a) density from 0.910 to 0.930 g/cc; b) melt index (I2) from 0.1 to 0.5 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.928 g/cc; b) a melt index (I2) from 0.1 to 0.8 g/10 min; and c) a high density fraction in an ATREF short chain branch distribution (SCBD) curve, eluting above 92° C., of greater than 10 percent to less than 28 percent of the total ATREF SCBD curve area. The invention also provides a hollow tube comprising at least one component formed from a composition comprising an ethylene-based interpolymer that comprises the following features: a) a density from 0.919 to 0.

Abstract: The instant invention is a high-density polyethylene composition, method of producing the same, articles made therefrom, and method of making such articles. The high-density polyethylene composition according to instant invention includes a first component, a second component, and a third component. The first component is a high-density polyethylene polymer having a density in the range of 0.940 to 0.980 g/cm3. The second component is polyethylene glycol, and the third component is octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate. The high-density polyethylene composition of the instant invention has a Yellowness Index of less than about ?2.5 at 0 hour of accelerated aging at 100° C. according to ASTM D-6290. The process for producing the high-density polyethylene composition according to instant invention includes the following steps: (1) providing a first component, wherein the first component is a high-density polyethylene polymer having a density in the range of 0.940 to 0.

Abstract: A remote control holding device that rests on the arm of a recliner, chair, sofa, loveseat or the like with a slot for a remote control. The holder preferably will have at least one extra pouch for a further remote control and one for magazines, snacks, newspapers and the like. The holder is adjustable to allow for different size furniture and also different size remote controls through a sliding track mechanism and is also preferably higher at the front end than the matching rear end. Differing amounts of pouches can be attached depending on requirements. A remote control rest can be turned through 180 degrees to accommodate left and right handed users.

Abstract: A process for polymerizing polyethylene with chromium-based catalysts wherein one or more supported chromium-based catalysts is mixed with mineral oil to form a slurry and the slurry is then introduced into a polymerization reactor, especially a gas-phase polymerization reactor.

Abstract: A process for polymerizing polyethylene with chromium-based catalysts wherein one or more supported chromium-based catalysts is mixed with mineral oil to form a slurry and the slurry is then introduced into a polymerization reactor, especially a gas-phase polymerization reactor.

Abstract: An improved method of maintaining data throughput during handoff in a wireless communication link operating with the Mobile IP protocol is described. A first base station initially servicing a mobile subscriber unit is associated with a first Mobile IP foreign agent that is registered with the Mobile IP home agent as a first mobility binding between the subscriber unit and the home agent. When the subscriber unit issues a request to be handed off from the first base station to a second base station, a second foreign agent associated with the second base station is registered with the home agent as a simultaneous binding with the first mobility binding between the subscriber unit and the home agent. This permits both foreign agents to simultaneously receive a sequence of data packets from the home agent. Before handoff is executed, the data packet sequence routed to the second foreign agent is stored at the second base station.

Abstract: A process and apparatus for periodically dumping liquids in an installation, in which liquids are recycled or otherwise accumulate dissolved and/or suspended contaminants, which process and apparatus makes use of a container for a liquid which is alternately filled and drained during operation of the installation, resulting in changing weight or buoyancy of the container or level of a float in the container, which actuates a dumping valve when a given critical weight, buoyancy or float level is exceeded or reduced.